Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 973.8 5.8 (0.6%) Market Cap: 107.30 Bil Enterprise Value: 99.48 Bil PE Ratio: 28.77 PB Ratio: 3.98 GF Score: 94/100

Regeneron Pharmaceuticals Inc at J.P. Morgan 2019 Spring Biotech Conference Call Transcript

Mar 15, 2019 / 05:00PM GMT
Release Date Price: $414.47 (+1.71%)
Operator

Welcome, and thank you all for standing by. I would like to inform all participants that this call is being recorded and will be available to clients of JPMorgan. Parts of this conference call may also be reproduced in JPMorgan research. If you have any objections, you may disconnect at this time.

This call is not intended for EEA clients that only subscribe for written research and members of the press are not permitted on this call. If you are with the press or are subject to MiFID II and do not have high touch access, please disconnect now. (Operator Instructions)

I would now like to turn the call over to Cory Kasimov. Please go ahead.

Cory William Kasimov
JP Morgan Chase & Co, Research Division - Senior Biotechnology Analyst

Great. Thank you, Sheena, and good afternoon, everyone. My name is Cory Kasimov. I'm a senior biotechnology analyst at JPMorgan, and I'm here with Matthew Holt from our team. Thanks for joining us for the latest installment of our 2019 Spring Biotech Conference Call series, where, today, it's our pleasure to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot